Julien Mamet
Principal investigator, leads ADYNXX, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$603KFederal grants as PI1 awards
5Patents grantedLatest Oct 8, 2019
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
1 awards · $603K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 23, 2019 | NIH | SBIR Phase I Pharmacokinetic and toxicology studies of AYX2, a transcription factor decoy, non-opioid, disease modifying drug candidate for the long-term treatment of chronic pain | $603K | ADYNXX, INC. |
6 patents as inventor
- US 10041069ADYNXX, INC.Aug 7, 2018
- US 10287583ADYNXX, INC.May 14, 2019
- US 10434178ADYNXX, INC.Oct 8, 2019
- US 9290762ADYNXX, INC.Mar 22, 2016
- US 9700624ADYNXX, INC.Jul 11, 2017
- US ADYNXX, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,184
Awards as PI#2,176
Patents#25
Companies
- ADYNXX, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.